Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which drug wins? labetalol vs lignocaine for safer intubation in gallbladder surgery

NCT ID NCT07192081

Symptom relief Sponsor: Dr. Waseem Ullah Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether labetalol or lignocaine (lidocaine) is better at preventing sudden rises in heart rate and blood pressure when a breathing tube is inserted for gallbladder surgery. 116 adults having elective laparoscopic gallbladder removal will receive one of the two drugs before intubation. The goal is to see which keeps vital signs more stable, helping anesthesiologists choose the safer option.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
labetalol and lignocaine (lidocaine)
What this could lead to
If one drug works better, it could become the preferred choice for keeping patients stable during intubation for gallbladder surgery.
What could go wrong
This is a small, early-stage trial (116 people) comparing two common drugs. Results may not apply to other surgeries or patients with health problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 116 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ASA Grade I and II * Age 18 to 60 years * Elective laparoscopic cholecystectomy * Both genders * Informed consent given Exclusion Criteria: * Hypersensitivity to labetalol/lignocaine * Hypertensive on antihypertensives * ASA Grade III or more * Cardiovascular, renal, hepatic, or endocrine issues * Pregnant/lactating * BMI ≥ 35 * Anticipated difficult airway

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholelithiasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia Hemodynamic response to laryngoscopy Intubation Laparoscopic cholecystectomy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hayatabad Med Complex

    RECRUITING

    Peshawar, Khyber Pakhtunkhwa, 25000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.